In this Issue:
CD47 blockade by Hu5F9-G4 and rituximab in NHL
Inotuzumab + mini-HCVD ± blinatumomab in ALL in first salvage
Chemo-free initial treatment of indolent lymphoma
Cost effectiveness of CAR T-cell therapy in paediatric ALL
Lomustine + chemo in elderly AML
Frontline VR-CAP vs R-CHOP in transplantationineligible MCL
PET response after immunochemotherapy for follicular lymphoma
Treatment-free remission after nilotinib in CML
Obinutuzumab ± chemo for CLL
Lenalidomide + rituximab as initial treatment of MCL
Please login below to download this issue (PDF)